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author and source are credited.Sleep and inflammation in resilient aging
Michael R. Irwin1,2
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Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California,
Los Angeles, CA, USA
Sleep quality is important to health, and increasingly viewed as critical in
promoting successful, resilient aging. In this review, the interplay between
sleep and mental and physical health is considered with a focus on the role
of inflammation as a biological pathway that translates the effects of sleep
on risk of depression, pain and chronic disease risk in aging. Given that
sleep regulates inflammatory biologic mechanisms with effects on mental
and physical health outcomes, the potential of interventions that target sleep
to reduce inflammation and promote health in aging is also discussed.1. Introduction
Recent years have seen increasing public health attention to the contribution of
sleep quality to health. Furthermore, this relationship is especially salient in
older adults who are at risk for sleep disturbance, as well as chronic diseases
of aging. Indeed, in two separate reports from the Institute of Medicine,
Health and Behavior [1,2], a range of research aimed at understanding the inter-
play among biological, behavioural and social factors in health and disease was
identified and integrated. In this review, we consider the role of sleep in pro-
moting healthy, resilient aging. First, we discuss the myriad effects of sleep
on health and the associations between sleep disturbance and physical health
outcomes. Second, given that subjective symptoms such as pain and depression
often compromise quality of life in older adults and diminish successful aging,
we consider the role of sleep in adaptation to the psychosocial and physical
challenges of aging and the contribution of sleep and/or its disruption to
pain perceptions and depressive symptoms. Third, we identify the reciprocal
links between the central nervous system and the immune system, which
together organize responses to infections and other challenges. Indeed, regu-
lation of inflammatory biology dynamics appears to be a key biologic
pathway that determines to what the degree an older adult is able to maintain
health. Conversely, activation of inflammatory signalling can increase risk for
disease, and also induce depressive symptoms, which together compromise
resilient aging. Finally, because sleep regulates inflammatory biologic mechan-
isms, we consider the potential of interventions that target sleep to reduce
inflammation and promote health in aging.2. Definition of resilience
Resilience is a dynamic process whereby an individual exhibits adaptation in
response to significant adversity [3]. Defined by psychological aspects of
coping, as well as physiological recovery from stress, resilience reflects a
two-way interaction between exposure to adversity and successful or positive
recovery to that challenge. In addition, resilience is also defined as a successful
adaptation to a condition that may be ongoing, which places the individual at
risk for negative outcomes such as medical morbidity or depression. For
example, successful aging represents a resilient response to the cumulative,
additive and possibly exponential risks associated with old age. Conversely,
when there is an absence of clinical symptoms, psychiatric distress or
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2deterioration in health despite age-related physiological vul-
nerability and ongoing challenges to the social environment
(e.g. loss of friends and family) and individual resources
(e.g. health), an older adult is showing an adaptive response
to the specific tasks of life consistent with successful aging.
Importantly, risk factors may be cumulative, and carry addi-
tive effects, when they co-occur as found in aging [3]. In sum,
resilience is conceptually characterized, along a continuum of
adaptation or success, as an active response to either discrete
adverse events, or to ongoing and cumulative conditions of
psychobiological challenge including chronic medical con-
ditions. In turn, resilience is also characterized by reduced
chronic medical burden or the absence of disability due to
such medical conditions. Resilience is different from strengths
or assets, which are viewed as static characteristics.s
4:201400093. Features of successful aging
When an individual reaches old age, accumulating negative
conditions represent a serious challenge to the capacity to
adapt and likely reduce the quality of life. Indeed, only 35.8%
of older adults are defined as ‘successful agers’ [4]. Themost fre-
quent correlates of the various definitions of successful aging are
age (young-old), non-smoking, absence of disability due to
chronic medical disorders such as arthritis and cardiovascular
disease, fewer medical disorders and absence of depression.
By contrast, continuity of resilience into retirement years is
unaffected, for example, by gender and education.Nevertheless,
in a study of 205 community-dwelling elderly, 92% of the
participants rated themselves as aging successfully [5], even
in the presence of chronic medical illness, which suggests
that individual characteristics rather than external events
(e.g. comorbid illness, income) determine successful aging.
However, little is known about the biobehavioural determinants
of resilient aging, although multiple biological systems likely
relate to the states of reduced risk of medical comorbidities,
disability and depression.4. Sleep and healthy aging
Restorative sleep is hypothesized to be one determinant of resi-
lience to life challenges, with increasing evidence suggesting
that adequate sleep amounts and sleep quality promote
healthy, successful aging along physical (e.g. medical morbid-
ity), psychological (e.g. depression and pain) and biological
domains (e.g. inflammation). Conversely, sleep disturbance
might be conceptualized as an adverse condition, which
increases risk for chronic disease and depression in older
adults. Indeed, as reviewed below, alterations of sleep wake
activity have potent effects on health outcomes including
domains of mortality, chronic disease morbidity, depression
and hyperalgesia.
Poor sleep is one of the most common complaints in older
adults. Even in healthy seniors, prevalence rates of insomnia
exceed 20–30%, greater in frequency and severity than any
other age group [6–8]. Indeed, normal aging is associated
with declines in subjective sleep quality, sleep fragmentation,
increases of light (stages 1 and 2) sleep and decreases of deep
slow-wave sleep [9–12].
Adequate sleep amounts appear to promote lower rates of
medical morbidity, with an optimal amount of sleep around
7 h per night. Indeed, more than 40 epidemiologic studieshave demonstrated a U-shaped association of sleep duration
with mortality, with the lowest mortality associated with
approximately 7 h of self-reported sleep [13–18]. This associ-
ation has been demonstrated in studies of more than 1 million
participants, statistical control for up to 30 potential comor-
bidities and covariates, and follow-up durations as long as
10–20 years [19]. Similar patterns have been noted for men
and women and all adult age strata, though older adults
have shown the highest mortality rates, and the greatest
excess mortality associated with short and long sleep.
In addition to mortality risk, similar U-shaped associations
have been found between sleep duration andmultiple morbid-
ities, including heart disease [20], stroke [21], hypertension
[22], diabetes [23], depression [18], obesity and metabolic syn-
drome [24]. As reviewed below, short and long sleep are
associated with inflammation [25], which might contribute to
these morbidities. Of course, epidemiologic data cannot fully
prove that short or long sleep causes mortality/morbidity. If
short or long sleep truly causes morbidity—which could
only be tested with controlled trials—then modest changes in
sleep duration could have a significant impact on health and
possibly mortality. Indeed, short or long sleep would be the
fifth leading cause of death in the USA [26] were short or
long sleep duration to cause all the deaths with which it has
been associated in epidemiologic studies.
Furthermore, the absence of sleep complaints (i.e. when
sleep is reported as adequate and restorative) might also
have protective effects on health, given naturalistic obser-
vations that difficulties with sleep have converse health
implications. For example, epidemiological data have
found that self-reported difficulties with sleep maintenance
(i.e. insomnia) act as a prospective predictor of cardiovascular
and non-cardiovascular disease mortality, particularly in com-
munity elderly populations [6,13,20,27–32]. Furthermore,
electroencephalogram measures confirm that older adults
who routinely take longer than 30 min to fall asleep have
higher rates of mortality as compared with those with short
sleep latency; this association is found over and above the con-
tribution of other known factors (e.g. age, gender and medical
burden) in older adults (odds ratio (OR) 1.7) [28].5. Sleep and depression risk in aging
Good sleep quality, as defined by self-reported sleep that
is restorative and maintained throughout the night, also
appears to be protective of mental health in older adults.
A recent meta-analysis of longitudinal epidemiologic studies
found that self-reported insomnia substantially increases the
risk of depression. Indeed, insomnia symptoms increased
the depression risk by over twofold (OR: 2.6, confidence
interval: 1.98–3.42), although results were heterogeneous
[33]. However, findings in older adults are limited, with
only six studies identified in this age group, including clinical
and primary care populations [34–39]. Furthermore, only
two prospective studies describe the effect of sleep disturb-
ance on depression risk in community-dwelling older
adults [34,38], with some evidence that the effects of sleep
disturbance on depression is only found in those with a
prior history of depression [34] or when sleep disturbance
is persistent [40]. Indeed, sleep disturbance is more robustly
related with depression recurrence, as opposed to its new
incidence, in older adults [34,40].
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36. Sleep and pain
Pain is also a common complaint that contributes to disability in
older adults. However, little is known about whether adequate
sleep might diminish hyperalgesia in those at risk for chronic
pain such as older adults with chronic medical conditions
such as osteroarthritis or patients with rheumatoid arthritis.
Nevertheless, observational and experimental studies suggest
that sleep and/or its disruption contribute to hyperalgesia. For
example, cross-sectional studies in rheumatoid arthritis patients
have found that sleep disturbance correlates with greater pain
and disease activity [41,42], which indicates increased medical
burden. Additionally, polysomnographic studies show that
chronic pain is associated with poor sleep continuity and
reduced total sleep time in other populations [43].
Whereas it is often thought that difficulties with sleep are
due to pain, sleep disturbance and pain appear to be bidirec-
tionally related. The occurrence of pain at night can disrupt
sleep, but it also is possible that sleep disturbance can drive
increased pain perception in the day after sleep. Whereas
data are constrained by small sample sizes, some experimen-
tal evidence shows that sleep loss increases pain reporting
[44–49]. In some instances, however, assessment of pain
has relied on self-reports without inclusion of comparison
controls, raising the possibility of confounding reporting
bias. Furthermore, many of the findings linking sleep disturb-
ance to pain perception may not be generalizable to the
clinical populations, as the manipulation selectively targeted
a particular sleep stage (e.g. rapid eye movement (REM)
sleep) or used total sleep deprivation. Most clinical popu-
lations, in contrast, evidence sleep loss during part of the
night or experience sleep fragmentation, which may not gen-
erate the same response as either loss of a sleep stage or sleep
throughout the entire night. Nevertheless, two studies have
found that selective slow-wave sleep deprivation decreased
mechanical pain thresholds [45,46], and one study found
that REM sleep deprivation increased thermal pain sensi-
tivity [48]. Similarly, total sleep deprivation reportedly
induces hyperalgesia or enhanced responsivity to painful
stimuli. Moreover, when sleep deprivation occurs over two
nights, increases of pain are even greater than after a single
night, suggesting a dose–response relationship [44,47,49].
Experimental fragmentation with disruption of sleep continu-
ity also has been found to induce spontaneous pain similar to
sleep restriction [50].
Recently, we have extended these observations and eval-
uated the resilient responses of rheumatoid arthritis versus
comparison controls to the challenge of sleep loss [51]. In
these studies, it was hypothesized that the at-risk population
of rheumatoid arthritis patients will show a failure to adapt to
sleep loss, which will lead to relatively greater and more per-
sistent elevations of pain. Consistent with this hypothesis,
rheumatoid patients appear to be less resilient to the chal-
lenge of sleep loss. As compared with controls, rheumatoid
arthritis patients show an exaggerated increase in symptoms
of pain after sleep loss. Furthermore, there is an activation of
disease-specific pain in rheumatoid arthritis patients in which
sleep loss was found to induce hyperalgesia, which was
accompanied by increases in the number of painful joints
and the severity of associated joint pain. Importantly, inde-
pendent clinician rating of painful and tender joints
confirmed increases in disease-specific pain following sleep
loss in rheumatoid arthritis patients.Sleep loss is also known to induce feelings of depression
and fatigue, which may co-occur or possibly exacerbate pain
perceptions given cross-sectional and prospective models
showing that depression, fatigue and pain are related.
Again, rheumatoid arthritis patients who face ongoing diffi-
culties with pain and sleep disturbance may be more
vulnerable or less resilient to the effects of sleep loss, which
would lead to relatively greater increases in self-reported
symptoms of depression and fatigue. Indeed, rheumatoid
arthritis patients have higher levels of depressed mood and
fatigue at baseline and show greater and more persistent
increases of these symptoms after sleep loss [51].7. Inflammation and aging
Increasing evidence also implicates inflammation as being a
key biologic pathway that determines to what degree an
older adult becomes vulnerable to chronic disease or main-
tains health in a model of resilient aging. In general, aging
is associated with an increased expression of proinflamma-
tory markers [52,53]. However, even though inflammation
is found in aggregate with aging, such activation of inflam-
matory signals is not universal. Indeed, only a fraction of
older adults appear to show increases in inflammation,
with some studies reporting that less than 25–30% of
older adults show elevated levels of systemic inflammation
(e.g. C-reactive protein, CRP) as defined by clinical threshold
criteria. Yet, among these older adults with elevated levels of
inflammatory cytokines, the risk for disability, morbidity
and mortality is greatest [54]. For example, increases of the
pleiotropic cytokine interleukin-6 (IL-6) have been found
to influence the onset and course of a wide spectrum of
age-associated diseases including cardiovascular disease,
arthritis, type 2 diabetes and certain cancers [52]. In older
adults, such elevated levels of IL-6 prospectively predict
future disability, declines of health status and mortality risk
[55,56]. The mechanisms that contribute to inflammation
during aging are not fully understood, although substantial
data indicate that aging impacts the efficiency of nuclear
factor (NF)-kB signalling. The NF-kB transcription control
pathway plays a key role in controlling cellular expression
of proinflammatory genes and activation of this signalling
pathway is implicated in the pathophysiology of diseases
such as cardiovascular disease and cancer [57].8. Inflammatory biology and mental health in
older adults
In addition to the effects of inflammatory biology on disease
risk, there is substantial evidence that levels of inflammatory
activation contribute to behavioural symptoms [58], which
might be related to the risk of depression in older adults. In
other words, adults who maintain low levels of inflammation
into older age may be more resilient to the challenges of
aging (i.e. bereavement, sleep disturbance and disability)
and may be less likely to have the onset of a depressive dis-
order [59]. Conversely, older adults who show activation of
inflammatory signalling may be more likely to evidence
symptoms of fatigue and depression, for example.
Peripheral proinflammatory signals are known to act
on the brain through key behaviour-modulating multiple
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4neurotransmitter systems including norepinephrine, dopamine
and serotonin [60]. Such activation of brain neurotransmit-
ter systems in turn activates a number of physiological and
behavioural responses, which are generally conceptualized as
sickness behaviours. In our studies, we have experimentally
examined the impact of inflammatory challenge on behavioural
responses by administering a low dose of endotoxin that
induces a rapid and transient increase in a numberof proinflam-
matory cytokines including IL-6 and tumour necrosis factor
(TNF). Experimentally induced increases in proinflammatory
cytokines influence the social or affective neural processes
that induce depressed mood [61,62]. Furthermore, biological
variability in the inflammatory response, as measured by circu-
lating concentrations of IL-6, is important in relating to
differences in neural responses from the experimental challenge
itself, in which greater IL-6 increases were associated with
greater activity in the anterior and posterior insula, regions
involved in both physical and social pain processing, and
activity in both of these regions correlated with increases in
depressed mood. Interestingly, males appeared to bemore resi-
lient to the behavioural and neural effects of the inflammatory
challenge as compared with females. [61]. In addition to indu-
cing greater increases in self-reported and observer-rated
depressed mood, inflammation diminishes the experience of
pleasure as indexedbysignificant reductions in ventral striatum
activity to reward cues [63].9. Sleep and inflammation
Sleep quality may buffer age-related increases in inflam-
mation. For example, greater sleep efficiency and more
positive social relations predicted lower levels of the inflam-
matory marker IL-6, whereas poor sleep efficiency and poor
social relations were associated with higher levels of IL-6
[64]. These findings indicate that sleep quality and social
support interact to predict risk of inflammation or that both
good sleep quality and adequate social support are protective
against age-related increases of inflammation.
Sleep amounts and sleep architecture also play a substan-
tial role in structuring overall inflammatory homeostasis.
Partial sleep loss is ubiquitous in clinical populations, as
well as older adults, and experimentally induced partial
sleep deprivation may impact the homeostasis of proinflam-
matory cytokine activity. In contrast to adequate sleep
amounts averaging 7–8 h in duration, sleep loss induces
increases in cellular and genomic markers of inflammation.
For example, partial sleep deprivation increases circulating
levels of inflammatory markers, such as IL-6, TNF-a and
CRP [65–67], with significant elevations after only one
night of sleep loss [67]. Additional studies have examined
the functional basis for altered inflammatory response after
sleep loss by measuring the production of proinflammatory
cytokines by monocytes following ligation of the toll-like
receptor 4 (TLR4) with lipopolysaccharide [68]. Such cellular
production of IL-6 and TNF due to aberrant increases of TLR
activity has been linked to inflammatory diseases such as
rheumatoid arthritis [69] and heart failure [70]. In the morn-
ing after a night of sleep loss, monocyte production of IL-6
and TNF-a was significantly greater relative to morning
levels following uninterrupted sleep. In addition, sleep loss
induced a more than threefold increase in transcription of
IL-6 mRNA and a twofold increase in TNF-a mRNA [68].The NF-kB transcription control pathway plays a key role
in the inflammatory signalling cascade, and sleep loss also
contributes to NF-kB activation [71]. Moreover, females
appear to be especially vulnerable to such activation of
inflammatory signalling processes, with greater increases
in activation of NF-kB as well as the cellular production of
IL-6 and TNF [71,72]. Activation of inflammatory biology
also appears to constitute one element of a more general
genomic response to sleep deprivation. Sleep deprivation
induces an upregulation of a gene ensemble that includes
the master circadian regulator, several ‘immediate early
genes’ marking cellular signal transduction and multiple
inflammatory response genes. Transcription factor-binding
motifs that were over-represented in the sleep deprivation
condition included the promoters of genes involved in regu-
lation by cAMP/PKA-induced transcription factors of the
CREB/ATF family, the PKC-induced AP-1 family, the proin-
flammatory NF-kB/Rel family and the MAP kinase-inducible
ETS transcription factor family typified by ELK1. In sum, the
leucocyte transcriptional response to sleep deprivation
involves multiple signal transduction pathways including
the NF-kB inflammatory signalling system.10. Interventions to promote healthy sleep:
relation to inflammation and well-being in
aging
Among older adults, the use of behavioural approaches for the
treatment of insomnia is increasingly viewed as an effective
and recommended alternative to pharmacologic therapies,
given that behavioural treatment can be administered without
the risk of side effects foundwith pharmacotherapy [73]. Three
recent meta-analyses support the efficacy of these behavioural
approaches [73–75], and one comparativemeta-analysis found
that behaviour therapy and pharmacologic treatments yielded
similar improvements in sleep maintenance, total sleep time
and sleep quality, with some advantage for behaviour treat-
ments in improving sleep latency [76]. Importantly, gains
from various behavioural treatments have been demonstrated
across all sleep outcomes with the exception of total sleep
time, with evidence from a few studies in older adults
that these benefits are sustained for months to years
following treatment.
The strategies used in behavioural treatments are hetero-
geneous and include various approaches ranging from
relaxation; behavioural focused treatments such as stimulus
control and sleep restriction; and multi-component cognitive
behavioural therapy that incorporates cognitive and behaviour-
al targets along with sleep hygiene and possibly relaxation
strategies. Despite the heterogeneity of these behavioural treat-
ments, gains from these various approaches, as compared with
placebo, do not differ substantially [74,75] as further reported in
a recent meta-analysis [77].
Given that adultswith insomnia symptomsare at substantial
risk for developing syndromal insomnia, preventive treatments
are also needed that target moderate sleep complaints prior
to the onset of insomnia. Indeed, there is some evidence that
physical exercise may enhance sleep quality, and King et al.
[78] demonstrated that 16 weeks of community-based exercise
training (i.e. endurance training, brisk walking and stationary
cycling) was superior to a wait-listed control condition on
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5measures of sleep quality in older adults with sub-syndromal
insomnia. In addition, recent interest has focused on the use of
a movement meditation, Tai Chi, to target insomnia symptoms.
Forexample, Li et al. [79] demonstratedgreater benefit of TaiChi,
as compared with stretching exercise, on sleep-quality out-
comes, although this study did not include a non-treatment
control group. Irwin et al. have found that Tai Chi Chih
a westernized and standardized version of Tai Chi [80] indu-
ced significant improvements in sleep quality [81]. Finally,
it is important to note that recent controlled trial data pro-
vide some promising evidence that Tai Chi may mitigate
inflammation in older adults [82]. Likewise, other randomized
controlled trials have documented reductions in proinflamma-
tory cytokine activity following cognitive behavioural therapy
[83] and meditation [84].s
4:2014000911. Conclusion
Restorative sleep is an important behavioural determinant of
resilient aging. Successful aging is defined in part by the
absence of medical and mental health morbidities or byreduced chronic medical burden in the face of chronic medical
condition,which together are associatedwith adequate amount
of sleep or good sleep. Conversely, when sleep wake activity is
disrupted, successful adaptation to adverse challenges is com-
promised with increases in reporting of symptoms of pain, as
well as depression. Sleep also contributes to the homeostatic
regulation of inflammatory biology dynamics, with evidence
that adequate sleep buffers age-related increases in inflam-
mation, which likely translate into more positive health
outcomes and lower risk of depression. Given these findings,
efforts to promote healthy sleep habits andmaintain sleep qual-
ity in aging have the potential to reduce inflammation and to
build resilience in aging.
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